Official UK procurement notice
MenACWY Vaccine · UK public procurement notice
Authority: Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency (Central government)
What is being bought
Published requirement descriptionProvision for the supply of a vaccine to protect against meningococcal disease caused by Neisseria meningitidis groups A, C, W and Y (MenACWY)
CPV: Vaccines
The lotProcurement structure
single lot · no lot value publishedLot #1The provision of a vaccine to protect against meningococcal disease caused by…Awarded
The provision of a vaccine to protect against meningococcal disease caused by Neisseria meningitidis groups A, C, W and Y, to be used as part of the national childhood immunisation programme.<br/>The contracting authority estimates their requirement over the period of the contract, including the period of the optional extension to be up to<br/>4.7 million doses of vaccine.<br/>Deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months. Additional information: Value - this information is considered by the supplier to be commercially sensitive information. The authority is not publishing the value so as not to prejudice the legitimate commercial interest of the supplier
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published sub-criteria (4)
- Comparison with specification: 40%
- Risk to programme delivery: 20%
- Price: 30%
- Social value: 10%
Published award criteria (4)
- Comparison with specification: 40
- Risk to programme delivery: 20
- Social value: 10
- Price: 30
- Price carries 30 of 100 points: a 10% discount moves about 3 points. The method statement decides this lot, not the discount.
Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- No (one-off requirement)
- First published
- 9 Feb 2022, 16:02 GMT
- Last source update
- 20 Jul 2022, 14:00 BST
- Award evaluation window
- 18 Mar 2022 – …
- Authority reference
CM/PHV/23/15697- FTS notice number
2022/S 000-019774- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-03154cFind a Tender
Publisher note: The contract(s) is for the benefit of the contracting authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments and their executive agencies or non-departmental public bodies charged with the delivery of healthcare or health related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers. The resulting products delivered against the contract(s) may be made available to the UK devolved administrations, Crown Dependencies and British Overseas Territories to undertake their respective vaccination programmes.
How it was run
Official noticeTender documents are also served through a separate tool: http://health.atamis.co.uk ↗
- Submission deadline
- 18 Mar 2022, 13:00 GMT
- Submission channel
- {"electronicSubmission","written"}
- Accepted languages
- en
- Bid validity
- 180 days from the deadline
- Bids opened
- 18 Mar 2022, 14:00 GMT
Timeline
18 Mar 2022 → 1 Aug 2023 · 4 dates- Submission deadline18 Mar 2022, 13:00 GMT
- Bids opened18 Mar 2022, 14:00 GMT
- Notice published20 Jul 2022, 14:00 BST
- Contract starts1 Aug 2023, 00:00 BST
Notice history
1 event · 3 releases on Find a Tender- Status changed to complete19 Jul 2022, 14:34 BST
Published amendments (1 · 0 deadline changes)
| When | What | Before | After | Shift |
|---|---|---|---|---|
| — | TextDescription of Procurement · II.2.4.1 | — | The provision of a vaccine to protect against meningococcal disease caused by Neisseria meningitidis groups A, C, W and Y, to be used as part of the national childhood immunisation programme. The contracting authority estimates their requirement over the period of the contract, including the period of the optional extension to be up to 4.7 million doses of vaccine. Deliveries will be required over… |
1 amendment published without a description.
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Aventis Pharma Ltd Trading As Sanofi | £1 † | — | Awarded |
Contracts
Contract 019668-2022-1 · Aventis Pharma Ltd Trading As Sanofi
- Signed
- 18 Jul 2022
- Value
- £1
- Period
- … – 31 Jul 2027
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 3bids · 3 electronic | 0 | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- The High CourtReview body
Bidders & participating suppliers
1 commercial party on the notice- Aventis Pharma Ltd Trading As SanofiAwarded supplier
Official documents & specifications (2)
Official links; attachments are not copiedTender pack and attachments
- Economic and financial selection criteria
- Technical selection criteria